Saturday, November 20, 2004
Shades of the Vioxx Case for Another Drug
Interesting dilemma. Right now, they need a prospective study to determine the risks of Bextra - however, it will be several years before the results are in. So, what to do in the meantime? I probably wouldn't prescribe this in those with cardiac risk factors - we may be going down the same Vioxx path.
Interesting dilemma. Right now, they need a prospective study to determine the risks of Bextra - however, it will be several years before the results are in. So, what to do in the meantime? I probably wouldn't prescribe this in those with cardiac risk factors - we may be going down the same Vioxx path.
Posted by Kevin |
link
| Comments (0)
| 
Comments: Post a Comment
